Watch NPCE. Know when insiders buy.
One email the day a filing lands. Free.
NPCE
NeuroPace Inc
13.05
−0.46 −3.40%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
32
FLAG · shorts 32
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $447.9MP/E —DIV YIELD —FCF YIELD -2.59%REV TTM $98.8M +16.9%NET INCOME −$19.1MNET DEBT $46.5M52W 9.40 – 19.29SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $22.8M | +17.1% | 82.8% | −$5.1M | −$6.2M | — | -0.18 | −$3.9M | $125K | −$4M | Aug 11 |
| Q1 2026 · Mar 31 | $22.1M | −2.0% | 81.8% | −$5.6M | −$6.7M | — | -0.20 | −$5.9M | $117K | −$6M | Aug 11 |
| Q4 2025 · Dec 31derived | $26.6M | +23.9% | 77.4% | −$1.8M | −$2.7M | — | -0.08 | $506K | $97K | $409K | Aug 11 |
| Q3 2025 · Sep 30 | $27.4M | +29.9% | 77.4% | −$2.6M | −$3.5M | — | -0.11 | −$1.9M | $30K | −$2M | Nov 4 |
| Q2 2025 · Jun 30 | $19.5M | +1.3% | 83.1% | −$8.2M | −$8.7M | — | -0.26 | −$2.1M | $168K | −$2.3M | Aug 11 |
| Q1 2025 · Mar 31 | $22.5M | +24.3% | 77.0% | −$5.1M | −$6.6M | — | -0.21 | −$7.5M | $37K | −$7.5M | Aug 11 |
| Q4 2024 · Dec 31derived | $21.5M | +19.2% | 75.4% | −$3.7M | −$5.3M | — | -0.17 | −$4.8M | $39K | −$4.8M | Mar 3 |
| Q3 2024 · Sep 30 | $21.1M | +28.2% | 73.2% | −$4.2M | −$5.5M | — | -0.19 | −$1.7M | $100K | −$1.8M | Nov 4 |
| Q2 2024 · Jun 30 | $19.3M | — | 73.4% | −$6.2M | −$7.5M | — | -0.26 | −$3.9M | $63K | −$4M | Nov 4 |
| Q1 2024 · Mar 31 | $18.1M | — | 73.6% | −$7.5M | −$8.9M | — | -0.32 | −$7.5M | $104K | −$7.6M | Nov 4 |
| Q4 2023 · Dec 31derived | $18M | — | 75.2% | −$5.1M | −$6.2M | — | -0.22 | −$3.3M | $32K | −$3.4M | Mar 4 |
| Q3 2023 · Sep 30 | $16.4M | — | 74.5% | −$6M | −$7.3M | — | -0.28 | −$2.3M | $9K | −$2.3M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $100M | 77.2% | −$16.3M | −$21.5M | -21.5% | -0.66 | −$11M | $332K | −$11.3M | $49.5M | — |
| FY2024 · to Dec 31 | $79.9M | 73.9% | −$21.7M | −$27.1M | -34.0% | -0.93 | −$17.9M | $306K | −$18.3M | $0 | — |
| FY2023 · to Dec 31 | $65.4M | 73.6% | −$27.2M | −$33M | -50.4% | -1.27 | −$19.7M | $173K | −$19.9M | — | — |
| FY2022 · to Dec 31 | $45.5M | 71.4% | −$40.8M | −$47.1M | -103.4% | -1.91 | −$36.9M | $603K | −$37.5M | — | — |
| FY2021 · to Dec 31 | $45.2M | 74.0% | −$23.7M | −$36.1M | -79.9% | -2.17 | −$24.6M | $384K | −$25M | — | — |
| FY2020 · to Dec 31 | $41.1M | 73.6% | −$13.1M | −$24.3M | -59.0% | -117.85 | −$21.6M | $62K | −$21.7M | — | — |
Every number comes from NeuroPace Inc's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.